Stay updated on Foralumab Safety in NASH and T2DM Clinical Trial
Sign up to get notified when there's something new on the Foralumab Safety in NASH and T2DM Clinical Trial page.

Latest updates to the Foralumab Safety in NASH and T2DM Clinical Trial page
- Check3 days agoChange DetectedA new revision entry (v3.5.4) is added to the study record history, replacing the previous v3.5.3 to reflect an update in the page's revision history.SummaryDifference0.1%

- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check25 days agoChange DetectedThe page footer/UI now reflects a newer site build revision (v3.5.3 instead of v3.5.2) without changing the displayed clinical trial history details.SummaryDifference0.1%

- Check32 days agoChange DetectedAdded revision v3.5.2 to the study record history and removed revision v3.5.0.SummaryDifference0.1%

- Check61 days agoChange DetectedRecord history shows revision v3.5.0 added and revision v3.4.3 removed.SummaryDifference0.1%

- Check75 days agoChange DetectedThe history now includes revision v3.4.3, while revision v3.4.2 is removed.SummaryDifference0.1%

- Check96 days agoChange DetectedA new revision v3.4.2 is added to the study history, and the previous revision v3.4.1 is removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Foralumab Safety in NASH and T2DM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Foralumab Safety in NASH and T2DM Clinical Trial page.